Skip to main
MEDP
MEDP logo

Medpace Holdings (MEDP) Stock Forecast & Price Target

Medpace Holdings (MEDP) Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 0%
Buy 10%
Hold 60%
Sell 10%
Strong Sell 20%

Bulls say

Medpace Holdings is poised for growth, with expectations of passthrough revenues increasing by 200-300 basis points in the second half of the year compared to already elevated levels in the second quarter. The company's strong performance in the first quarter, highlighted by higher request-for-proposals (RFP) volume, suggests a favorable trend in demand for its services. Additionally, Medpace anticipates a return to a book-to-bill ratio exceeding 1.15x in the third quarter, indicating robust business development and a positive outlook for future revenue generation.

Bears say

Medpace Holdings has faced significant challenges, evidenced by a persistent level of backlog cancellations that remain at or above the upper range of what the company deems normal, although they recently declined to the lower end of this range in Q2. Furthermore, despite a forecasted adjusted EBITDA growth for 2025 and 2026, the company anticipates continued hiring in direct service costs, which may pressure overall profitability. Additionally, the uncertainty surrounding the expected growth of Direct Service revenue raises concerns over future financial performance, reflecting a cautious outlook moving forward.

Medpace Holdings (MEDP) has been analyzed by 10 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 10% recommend Buy, 60% suggest Holding, 10% advise Selling, and 20% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medpace Holdings (MEDP) Forecast

Analysts have given Medpace Holdings (MEDP) a Hold based on their latest research and market trends.

According to 10 analysts, Medpace Holdings (MEDP) has a Hold consensus rating as of Oct 30, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $451.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $451.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medpace Holdings (MEDP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.